Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent radiochemotherapy and surgery in NSCLC – Phase II multicenter study
2004-005027-18Phase 2Completed
- Sponsor
- Policlinico Gemelli
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of gemcitabine and cisplatin in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), sponsored by Policlinico Gemelli. Primary endpoints: Clinical response, Feasibility and 7 more. Started Aug 2007; status: completed.
02
Drugs
gemcitabinecisplatin
03
Conditions
non-small cell lung cancer (NSCLC)small cell lung cancer (SCLC)
Beyond the preview
Go deeper on 2004-005027-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005027-18.